FDA Inspection 1281950 — STERIS Schweiz AG
The FDA completed an inspection of STERIS Schweiz AG on January 24, 2024 in Daniken. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Daniken (Switzerland)
Additional Details
Mutual Recognition Agreement (MRA)